ArticleNature metabolism2020

Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes.

Erica P Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.